RVLPQ

RVL PHARMACEUTICALS PLC by RVL Pharmaceuticals plc (RVLPQ)

About RVL PHARMACEUTICALS PLC by RVL Pharmaceuticals plc (RVLPQ)

RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
1,062
P/E ratio
--

RVL PHARMACEUTICALS PLC by RVL Pharmaceuticals plc News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
1,062
P/E ratio
--